According to a recent analysis by Emergent Research, the market for Clinical Decision Support Systems (CDSS) Market is anticipated to reach USD 2,406.2 Million by 2027. The market for clinical decision support systems (CDSS) in areas including medication databases, diagnostic decision support, care plans, and disease reference, among others, is benefiting from the rising prevalence of chronic diseases around the world. A growing tendency of more patients entering hospitals as a result of the rise in chronic illness will increase the amount of data kept on hand by the hospitals. To handle the data effectively, a precise and error-free tool would be required; here is where clinical decision support systems (CDSS) come into action.
In a standard CDSS, the features of each patient are matched to a computerized clinical knowledge base, and patient-specific tests are presented to the practitioner to help them make an educated decision. This software is created to be direct aid to clinical decision-making. In recent years, CDSS have been utilized more frequently at the point of care to assist physicians in fusing their knowledge with the data and recommendations provided by the CDSS.
Growing research and development efforts have resulted in the creation of CDSS that can make use of data and observations that are frequently difficult for humans to understand. CDSSs use computerized provider order entry (CPOE) systems or web-based apps that interact with EHRs. Desktop, tablets, smartphones, and other devices like wearable health technologies and biometric monitoring can all be used to easily administer these systems. Some of the major providers of CDSS to enhance clinical decision-making are covered here.
Some Key Highlights from the Report :
The software segment is expected to grow at the highest rate during the forecast period
The CDSS industry is divided into three categories based on the component: services, software, and hardware. The services sector held the greatest share of this market in 2021. The recurring nature of services including training and development, installation, advising, and maintenance is credited with the segment’s growth.
The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2021
Clinical decision support systems are made available to end users in both on-premise and cloud-based delivery models. In 2021, the on-premise mode of delivery held the biggest market share for clinical decision support systems. On the other hand, the cloud-based method of delivery is predicted to increase at the highest CAGR because of this model’s lower capital costs and operating costs as well as its scalability, flexibility, and affordability
North America accounted for the largest share of the global clinical decision support systems market in 2021.
North America held the greatest market share for clinical decision support systems globally in 2021. The significant investments made in HCIT solutions, regulatory requirements favoring the implementation of CDSS, the presence of major market players in the area, and the rising incidence of medication errors in the US and Canada are all factors that contribute to the North American market’s sizeable share.
Key participants include Cerner Corporation, Epic Systems Corporation, Zynx Health, Allscripts Healthcare Solutions Inc., IBM, McKesson Corporation, Siemens Healthineers, Meditech, Philips Healthcare, and Wolters Kluwer Health, among others.
Emergen Research has segmented the global clinical decision support systems (CDSS) based on component, product, type, mode of delivery, level of interactivity, setting outlook, usage, application, end-user, and region:
Component Outlook (Revenue, USD Million; 2017-2027)
- Services
- Hardware
- Software
Product Outlook (Revenue, USD Million; 2017-2027)
- Integrated CDSS
- Standalone CDSS
Type Outlook (Revenue, USD Million; 2017-2027)
- Therapeutic CDSS
- Diagnostic CDSS
Mode of Delivery Outlook (Revenue, USD Million; 2017-2027)
- On-Premise CDSS
- Web-Based CDSS
- Cloud-Based CDSS
Level of Interactivity Outlook (Revenue, USD Million; 2017-2027)
- Active CDSS
- Passive CDSS
Setting Outlook (Revenue, USD Million; 2017-2027)
- Inpatient
- Ambulatory Care
Usage Outlook (Revenue, USD Million; 2017-2027)
- Knowledge-Based
- Expert Laboratory Information System
- Machine Learning Systems
Application Outlook (Revenue, USD Million; 2017-2027)
- Drug Databases
- Care Plans
- Diagnostic Decision Support
- Disease Reference
- Others
End-use Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Diagnostic Centers
- Clinics
- Retail Pharmacies
- Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- the U.S
- Canada
- Europe
- Germany
- the UK
- France
- BENELUX
- Rest of Europe
- the Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
To identify the key trends in the industry, Get the Link
